SPY345.78+1.17 0.34%
DIA283.34-0.31 -0.11%
IXIC11,548.28+42.28 0.37%

Morgan Stanley Maintains Overweight on Zealand Pharma, Raises Price Target to $45

Morgan Stanley maintains Zealand Pharma (NASDAQ:ZEAL) with a Overweight and raises the price target from $43 to $45.

· 10/13/2020 10:31
Morgan Stanley maintains Zealand Pharma (NASDAQ:ZEAL) with a Overweight and raises the price target from $43 to $45.